Concepedia

Vincent Haddad

VH

27

Publications

4.3K

Citations

20

H-Index

2006

Active since

Affiliations

Institut Gustave Roussy(Current)

Amgen (United States)

Amgen (United Kingdom)

AstraZeneca (United Kingdom)

Medical University of Vienna

Vincent Haddad is an author at Institut Gustave Roussy specializing in medicine, cancer therapeutics, and oncology.

ORCID

Top concepts

Publications per year

2006–2023

27

Publications

27

DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy

Ken A. Olaussen, Ariane Dunant, Pierre Fouret et al. · New England Journal of Medicine · 2006 · 1.7K citations · Full text

Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia

Nicola Gökbuget, Hervé Dombret, Massimiliano Bonifacio et al. · Blood · 2018 · 810 citations · Full text

Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patients

Sylvie Bonvalot, Hany Eldweny, Vincent Haddad et al. · European Journal of Surgical Oncology · 2007 · 271 citations

, , +5

Gefitinib Plus Chemotherapy Versus Chemotherapy in Epidermal Growth Factor Receptor Mutation–Positive Non–Small-Cell Lung Cancer Resistant to First-Line Gefitinib (IMPRESS): Overall Survival and Biomarker Analyses

Tony Mok, Sang‐We Kim, Yi‐Long Wu et al. · Journal of Clinical Oncology · 2017 · 183 citations

Phase II Trial of Consolidation Docetaxel and Samarium-153 in Patients With Bone Metastases From Castration-Resistant Prostate Cancer

Karim Fizazi, Philippe Beuzeboc, J. Lumbroso et al. · Journal of Clinical Oncology · 2009 · 173 citations · Full text

Rows per page

1–5 of 27